Pharmacy Podcast Network

Dr. Sandra Leal is currently the Executive Vice President SinfoniaRx, A TRHC Solution and APhA President. She has published and presented her work in numerous national and international publications and venues including Peru, Saudi Arabia, and Japan. She has been recognized as the Good Government Pharmacist of the Year by the APhA for her advocacy work on pharmacist provider status. Dr. Leal received two Pinnacle Award from the APhA Foundation for her progressive practice innovations and received the ASHP Best Practice Award for her leading practice in diabetes management. Facebook/Twitter/Instagram Handle @slealrx    LinkedIn Profile https://www.linkedin.com/in/slealrx National Center for Farmworker Health: www.ncfh.org Association of Clinicians for the Underserved: https://clinicians.org/ El Rio Health:  www.elrio.org Tabula Rasa HealthCare: https://www.tabularasahealthcare.com/ American Pharmacists Association: www.pharmacist.com APhA Annual Meeting Link: https://apha2021.pharmacist.com//index.asp? See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guests today are Michelle Sherman, RPh, who is a member of the Pharmacy Podcast Network & has a podcast called the "Conscious Pharmacist Podcast" & Jay Holloway PharmD, returning for a second time to the Pharmacy Podcat to discuss:  References, from Pharmacy Today: https://www.pharmacytoday.org/article/S1042-0991(20)30876-8/fulltext Pharmacists Focused on LGBTQ Communities, the latest chapter of the "Transforming a Nation" podcast series.  Pharmacists need to acquire foundational knowledge about key concepts and terminologies relevant to the LGBTQ population. To provide care consistent with cultural competence and humility, pharmacists must also be aware of the diversity between and within different segments of the LGBTQ community, and the intersectionality of multiple identities that shape a person’s life experiences. Furthermore, it is important to note that while various identities such as gender, sexual orientation, and gender identity intersect, one is not predictive of the other. For example, a person’s gender identity does not determine their sexual orientation and the biological sex designated at birth does not define their gender identity.11Sexual orientation is a person’s emotional, romantic, sexual attraction, or non-attraction to other people and is composed of three separate dimensions: behavior, identity, and desire. Some people may engage in same-sex sexual behavior but not identify as lesbian, gay, or bisexual. Similarly, a person may be sexually, romantically, or emotionally attracted to members of the same sex and choose not to be sexually active with same-sex partners. For research purposes, the terms “men who have sex with men” (MSM) and “women who have sex with women” (WSW) are often used to describe a person’s sexual behavior regardless of their identity. Sex refers to a set of biological attributes primarily related to physical and physiological features. The phrase “sex assigned at birth” (SAAB) or “designated sex at birth” (DSAB) is used to describe a person’s biological sex, most often, but not exclusively, based on the external appearance of genitalia at birth. Gender is a socially constructed concept used to characterize the behaviors, actions, and qualities of women and men or girls and boys. The critical flaw of an exclusive binary paradigm is that it does not account for the inherent diversity of human gender. A more expansive conceptualization of gender recognizes that each person possesses a wide range of characteristics that may or may not be consistent with the gender binary, represent a combination of male and female, or fall somewhere in between the two. Gender identity is a person’s inner sense of their gender. For some people, their gender identity may not be congruent with the one typically expected based on their SAAB/DSAB. They may describe themselves in a variety of ways including, but not limited to, transgender, male, female, gender fluid/genderqueer, nonbinary, agender, or as another gender. Decisions to change gender expression and/or physical appearance to be more consistent with their gender identity through medical (e.g., hormone replacement therapy), nonmedical (e.g., voice therapy, choosing an affirming name, etc.), and/or surgical options (e.g. gender affirmation/confirmation surgery) is wholly determined by the individual.  The National LGBTQIA+ Health Education Center   https://www.lgbtqiahealtheducation.org/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

RxSafe & ApproRx have sponsored a gathering of 200+ pharmacy owners interested in learning more about a drug manufacturer interested in working directly with Pharmacy owners. Thanks to Bruce Kneeland and Todd Eury for hosting this LIVE presentation from March 2nd 2021. Today was the 12th anniversary of the Pharmacy Podcast Network. The 1st podcast about the profession of pharmacy launched episode 1 on March 2nd 2009. Today the PPN has 30+ hosts & is dedicated to the success of our pharmacists & pharmacy techs. Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company. Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result. Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs. In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make. The Pharmacy Podcast Network is the global leader in podcast content for the Business & Profession of Pharmacy. Since March 2009, the Pharmacy Podcast was the first audio blog for the pharmacy industry and has developed into a directory of over 25+ podcasts with different vertical informational themes. Collectively, over 2.5M downloads, more than 2,000+ episodes, and 30+ participating Pharmacists and Pharmacy Professionals hosting the podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Janssen COVID-19 Vaccine: What Pharmacists Need to Know On February 27, the FDA authorized the emergency use of a COVID-19 vaccine developed by the Johnson & Johnson subsidiary, Janssen Biotech – the third such vaccine to be so authorized. What do pharmacists need to know about this product? Our guests are Michael Hogue, President of APhA and a member of the CDC working group on COVID vaccines, and Stephan Foster, APhA’s liaison to the CDC’s Advisory Committee on Immunization Practices. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

PAIN POD EPISODE 0 One of the most common definitions of pain describes pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” When we are exposed to something that causes pain, if able, we quickly or reflexively withdraw. The sensory feeling of pain is called nociception. What Does It Mean to Call Chronic Pain a Brain Disease? by Mark D. Sullivan https://www.jpain.org/article/S1526-5900(12)00560-3/pdf Multiple investigators have recently asked whether neuroimaging has shown that chronic pain is a brain disease. We review the clinical implications of seeing chronic pain as a brain disease. Abnormalities noted on imaging of peripheral structures have previously misled the clinical care of patients with chronic pain. We also cannot assume that the changes associated with chronic pain on neuroimaging are causal. When considering the significance of neuroimaging results, it is important to remember that ‘‘disease’’ is a concept that arises out of clinical medicine, not laboratory science. Our Host: Mark Garofoli, PharmD Clinical Assistant Professor WVU School of Pharmacy (Department of Clinical Pharmacy) WV School of Pharmacy curriculum education in areas of expertise such as pain management, substance-use disorder, medication therapy management, managed care, geriatric care, management, leadership, and experiential learning. Brian Regan - The Emergency Room https://youtu.be/d2Vg3iSd5ms See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The recently published (in a pre-print server) COLCORONA study, sponsored by the Montreal Heart institute and conducted in 6 countries aimed to show if using colchicine would decrease risk of hospitalization and death in outpatients with COVID-19. Will it work? How's the study design? Learn the facts. Reference: Tardif J, Bouabdallaoui N, L'Allier P, et al. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Pre-Print. https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1 CPE details for GameChangers Podcast March 2021 Learning Objective: Apply the results of the CORCORONA study to patients with COVID-19 disease. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Gil Bashe, Managing Director of Finn Partners and Medika Life’s top 25 most influential voices in healthcare for 2021 joins Todd Eury on a discussion about our nation’s health disparities and our healthcare system’s reflection of a broken system. Interact w/ Gil on twitter, here: https://twitter.com/Gil_Bashe  References: Angelina Zayas, co-founder of the Grace and Peace community center, turned her church into a food bank on Chicago's northwest side. Just 4% of residents in the ZIP code received the first dose of COVID-19 vaccine as of Sunday, according to data from the Chicago Department of Public Health. Similarly low vaccination rates exist in other majority-Latino and majority-Black neighborhoods across the city's south and west sides, despite COVID-19’s disproportionate impact on those populations. https://www.usatoday.com/in-depth/news/health/2021/02/12/data-analysis-chicago-vaccine-rollout-reflects-us-racial-disparities/4418978001/ Bashe, named by Medika Life as one of the top 50 healthcare influencers, outlines why health care technology must be more accessible to people with urgent health needs. https://medika.life/fifty-of-the-most-influential-voices-in-healthcare-for-2021/ [The US government is throwing the kitchen sink at the Covid-19 national response. It’s doing so with an urgency so great that the Food and Drug Administration has issued Emergency Use Authorizations that tear down long-standing obstacles to telehealth, digital health, diagnostics and innovative medications that may prove effective against the virus.  By Gregg Girvan and Avik Roy The United States ranks 4th in the World Index of Healthcare Innovation, with an overall score of 54.96, behind only Switzerland, Germany, and the Netherlands. Americans are usually the first to gain access to major new medical advances, advances often discovered at American universities and developed by American companies. As a result, the U.S. ranked first for both Choice (57.65) and Science & Technology (75.14). https://freopp.org/united-states-health-system-profile-4-in-the-world-index-of-healthcare-innovation-b593ba15a96 Vaccine ‘Deserts’ Released in early February, the study, a white paper posted on the University of Pittsburgh’s website, found that in 69 counties, Black Americans would need to travel farther to get to sites such as hospital outpatient departments, federally qualified health centers and rural health clinics, and community pharmacies that formed the early backbone of large-scale vaccination efforts. The study, which used a sample population and geographic data supplied by the National Council for Prescription Drug Programs, the Centers for Medicare and Medicaid Services and the Health Resources and Services Administration, among others, found that some of the worst so-called “vaccine deserts” for Black people were in Georgia, Louisiana, Mississippi and South Carolina. In Lee County, Ga., for example, Black Americans are 825% more likely to live more than 10 miles from a vaccination location than whites. In Madison County, Miss., the figure is 976%. And in Chilton County, Ala., it’s 1,193%, the study found. But disparities are not limited to the rural South, according to lead investigator Lucas Berenbrok, PharmD, an assistant professor of pharmacy and therapeutics at UPMC School of Pharmacy. “Of those 69 counties, 23 are in urban areas, some are in the West and Southwest, and a few are in the Northeast,” Berenbrok said. “The point this analysis makes is that our existing health care infrastructure probably isn’t going to cut it in terms of achieving a good, equitable distribution of vaccines.” https://www.idse.net/Covid-19/Article/02-21/Pharmacy-s-Role-in-Addressing-Vaccine-Inequities/62669 This episode was sponsored by Ultiguard Safe Pack UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. https://omny.fm/shows/pharmacy-podcast-network/playlists/ultiguard-safe-pack-podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

PUTTcast Episode 14 What happens when independent pharmacies take charge of local health plans? Is it even possible? Join host Monique Whitney, PUTT President Scott Newman, and special guests Illinois pharmacy owner and independent pharmacy consultant, Cindi Reed; Michigan pharmacy owner and PUTT board member, Nathan Mair; and Population Health Manager at Mitigate Partners, Carl Schuessler; as they discuss how re-localizing care is not only realistic but good for local employers and economies. Listen to all the PUTTcast Episodes here:  https://www.truthrx.org/puttcast.html  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Special Guest:Jason Ausili, Chief Clinical Officer at FDS. Jason Ausili, Pharm.D., is the Chief Clinical Officer at FDS, Inc., where he’s focused on delivering innovative clinical-based technology solutions that help mobilize pharmacists as care providers and practice at the top of their license. Jason received his Doctor of Pharmacy degree from Butler University in 2002 and has over 20 years of experience working in a variety of areas within the industry. He’s held a variety of roles across the spectrum of community pharmacy and throughout his career has stayed centered on his aim to expand the scope of pharmacy practice, improve healthcare quality performance, and ensure pharmacists receive equitable payment for clinical services and improving patient outcomes. Prior to coming to FDS in 2017, Jason spent the previous two years at the National Association of Chain Drug Stores, a non-profit trade association, as the Director of Pharmacy Affairs. He has served on a number of pharmacy industry work groups over the years and has been actively involved with various professional organizations.   Background: In August 2020, the U.S. Department of Health and Human Services (HHS), through the Assistant Secretary for Health, issued guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they are made available. This guidance authorizes state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns acting under the supervision of the qualified pharmacist to administer, COVID-19 vaccinations to persons ages 3 or older, subject to certain requirements. In addition, President Biden has clearly stated his intention to make vaccinations available in all pharmacies across the country and just this week the federal government stated it plans to ship Covid-19 vaccines to retail pharmacies starting February 11th.   Challenges: Billing for a medical benefit is a new phenomenon for many community pharmacists. How can they align and integrate their current pharmacy management systems with expanded medical billing requirements? How will pharmacy’s align with patient vaccination registries to ensure automated reporting to state registries for reportable vaccine events? Solutions:  Pharmacists need to operate at the top of their licenses. They need to be able to integrate vaccination clinical documentation into their existing patient profiles. And will need to also provide efficient patient scheduling and an optimal patient experience. About FDS, Inc.: FDS strengthens the health of pharmacies and their patients. We empower community pharmacies to build the clinically focused New Era Pharmacy, enabling their business to thrive now and successfully transition to a provider of community and population health through data insights, purpose-built technology solutions, and clinical services enablement. Read more about FDS at www.fdsrx.com. FDS recently merged with Amplicare, a leading business intelligence and decision-automation platform in the pharmacy and healthcare industry. Designed by pharmacists for pharmacists, the platform is engineered with a big data approach. Amplicare's proprietary technology collects, analyzes, and leverages consumer, patient, clinical, and industry-level informatics to empower providers to proactively take informed actions that improve patient care and clinical outcomes.  With thousands of pharmacy subscribers, Amplicare delivers an unrivaled platform that increases patient retention, improves performance measures, grows and diversifies revenue streams, and enables providers to communicate with their patients more easily than ever before. Read more about Amplicare at www.amplicare.com. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

We talk with Community Pharmacy owner Dr. Steve Moore, PharmD about the Implications of the Rutledge versus PCMA Supreme Court decision on Independent Pharmacy.  About Condo Pharmacy:  Condo Pharmacy is an independently owned and operated pharmacy dedicated to meeting the unique healthcare needs of each individual patient. In addition to providing both traditional and specialty pharmacy services, Condo Pharmacy is proud to be a part of the CPESN USA network of pharmacies and offer enhanced pharmacy services and care management protocols. Special guest: Steve Moore, PharmD See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices